First characterization and emergence of SHV-60 in raw milk of a healthy cow in Japan

Journal of Veterinary Medical Science

Volumn 70, Issue 11, 2008, Pages 1269-1272

  Hammad, Ahmed M ^a   Ahmed, Ashraf M ^a,b   Ishida, Yojiro ^a   Shimamoto, Tadashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Kafrelsheikh University   (Egypt)

Author keywords

Klebsiella pneumoniae; Milk; SHV lactamase

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; CATTLE; CATTLE DISEASE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; JAPAN; KLEBSIELLA PNEUMONIAE; LACTATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MILK; MOLECULAR GENETICS; PUBLIC HEALTH;

ANIMALS; ANTI-BACTERIAL AGENTS; AZTREONAM; BETA-LACTAMASES; CATTLE; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; FEMALE; JAPAN; KLEBSIELLA PNEUMONIAE; LACTATION; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; MILK; MOLECULAR SEQUENCE DATA; PUBLIC HEALTH;

ANIMALIA; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 57349188460     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.70.1269     Document Type: Article

References (21)

1. Acer, J. F. and Moulin, G. 2006. Antimicrobial resistance at farm level. Rev. Sci. Tech. Off. Int. Epiz. 25: 775-792.
2. Arlet, G., Rouveau, M. and Philippon, A. 1997. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum β-lactamase. FEMS Microbiol. Lett. 152: 163-167.
3. Blowey, R. 2005. Balancing high production and health of cows. Advances in Dairy Technology. Proceeding of the Western Canadian Dairy. Seminar 17: 297-308.
4. Burgos, J. M., Ellington, B. A. and Varela, M. F. 2005. Presence of multidrug resistant enteric bacteria in dairy farm top-soil. J. Dairy Sci. 88: 1391-1398.
5. Chaves, J., Ladona, M. G., Segura C., Coira, A., Reig R. and Ampurdanes, C. 2001. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45: 2856-2861.
6. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing, 15th Iinformational Supplement. CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Fukigai, S., Alba, J., Kimura, S., Iida, T., Nishikura, N., Ishii, Y. and Yamaguchi, K. 2007. Nosocomial outbreak of genetically related IMP-1 β-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int. J. Antimicrob. Agents 29: 306-310.
8. Guzman, L. M., Dominique, B., Michael, J. C. and Jon, B. 1995. Tight regulation, modulation, and high-level expression by vectors containing arabinose PBAD promoter, J. Bacteriol. 177: 4121-4130.
9. Ko, W. C., Paterson, D. L., Sagnimeni, A. J., Hansen D. S., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., McCormack, J. G. and Yu, V. L. 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg. Infect. Dis. 8: 160-166.
10. Koch, A. L. 1981. Evolution of antibiotic resistance gene function. Microbiol. Rev. 45: 355-378.
11. Komatsu, M., Ikeda, N., Aihara, M., Nakamachi, Y., Kinoshita S., Yamasaki, K. and, Shimakawa, K. 2001. Hospital outbreak of MEN-1-derived extended spectrum β-lactamase-producing Klebsiella pneumoniae. J. Infect. Chemother. 7: 94-101.
12. Leedom, J. M. 2006. Milk of nonhuman origin and infectious diseases in humans. Clin. Infect. Dis. 43: 610-615.
13. Ma, L., Alba, J., Chang, F. Y., Ishiguro, M., Yamaguchi, K., Siu, L. K. and Ishii, Y. 2005. Novel SHV-derived extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin. Antimicrob. Agents Chemother. 49: 600-605.
14. Muratani, T., Kobayashi, T. and Matsumoto, T. 2006. Emergence and prevalence of β-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int. J. Antimicrob. Agents 27: 491-499.
15. Pfaller, M. A. and Segreti, J. 2006. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin. Infect. Dis. 42: S153-S163.
16. Roesch, M., Perreten, V., Doherr, M. G., Schaeren, W., Schällibaum M. and Blum, J. W. 2006. Comparison of antibiotic resistance of udder pathogens in dairy cows kept on organic and on conventional farms. J. Dairy Sci. 89: 989-997.
17. Sambrook, J. and Russell, D. W. 2001. Molecular Cloning: a Laboratory Manual, 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
18. Schroeder, J. W. 1997. Mastitis control programs: Bovine mastitis and milking Management. Available from: http://www.ag.ndsu.edu/pubs/ansci/dairy/ as1129w.htm.
19. Sturenburg, E. and Mack, D. 2003. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy and infection control. J. Infect. 47: 273-295.
20. Tollefson, L. and Flynn, W. T. 2002. Impact of antimicrobial resistance on regulatory policies in veterinary medicine: Status report. AAPS PharmSci. 4. Available from: http://www.aapspharmsci.org./view.asp?art=ps040437.
21. Yamasaki, K., Komatsu, M., Yamashita, T., Shimakawa, K., Ura, T., Nishio, H., Satoh, K., Washidu, R., Shohiro, K. and Aihara, M. 2003. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1 metallo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan. J. Antimicrob. Chemother. 51: 631-638.